CN113717998A - 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法 - Google Patents

重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法 Download PDF

Info

Publication number
CN113717998A
CN113717998A CN202111021701.XA CN202111021701A CN113717998A CN 113717998 A CN113717998 A CN 113717998A CN 202111021701 A CN202111021701 A CN 202111021701A CN 113717998 A CN113717998 A CN 113717998A
Authority
CN
China
Prior art keywords
ala
leu
gly
ser
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111021701.XA
Other languages
English (en)
Inventor
何平
戴柱
李浪
赵弘
方欣
樊卫
岳亮
宓鹏程
廖立新
丁小妹
于铁妹
潘俊锋
刘建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Ruidelin Biology Co ltd
Original Assignee
Zhuhai Ruidelin Biology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai Ruidelin Biology Co ltd filed Critical Zhuhai Ruidelin Biology Co ltd
Priority to CN202111021701.XA priority Critical patent/CN113717998A/zh
Publication of CN113717998A publication Critical patent/CN113717998A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00Biological treatment of water, waste water, or sewage
    • C02F3/34Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/01Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01178Diaminobutyrate acetyltransferase (2.3.1.178)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • C12Y206/01076Diaminobutyrate--2-oxoglutarate transaminase (2.6.1.76)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/01Hydro-lyases (4.2.1)
    • C12Y402/01108Ectoine synthase (4.2.1.108)

Abstract

本发明涉及微生物发酵技术领域,公开了重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法。本发明通过基因工程技术构建一株重组枯草芽孢杆菌,其能够利用酶法合成肌肽的废水进行发酵,并得到含四氢嘧啶的发酵液。经提取不仅可获得较多的四氢嘧啶,同时得到副产物菌渣蛋白饲料,而且排放的废水比原废水中COD、BOD、总磷、氨氮等下降70.4~96.2%,该方法还具有操作简便,节省资源,安全环保,成本低等优点,适合工业推广应用。

Description

重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四 氢嘧啶的方法
技术领域
本发明涉及微生物发酵技术领域,具体涉及重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法。
背景技术
四氢嘧啶(Ectoine)是许多耐盐和嗜盐微生物为维持渗透压平衡而在细胞内产生的一种相容性溶质,能够为处于外界高温、冷冻、射线、干燥等极端条件刺激下的细胞、蛋白质、细胞膜和核酸等提供保护作用。此外,四氢嘧啶对阿尔兹海默氏症、帕金森病等神经性疾病均有一定的疗效,并且最新研究发现四氢嘧啶能够提高皮肤的再生能力和延缓皮肤的老化。因此,四氢嘧啶在精细化工和生物医药等行业将具有广泛的应用前景。
目前,四氢嘧啶的生产方法主要通过嗜盐微生物(特别是盐单胞菌)的高密度发酵来获得。也有专利报导了转基因大肠杆菌工程菌(CN105018403A、CN106754603B、CN112280726A等)和转基因谷氨酸棒杆菌工程菌(CN107142234B、CN 110699310 A等)发酵产生四氢嘧啶,还有采用克劳氏芽孢杆菌、盐单胞菌发酵产生四氢嘧啶的。
目前现有的生产菌株及使用其生产四氢嘧啶的方法,均需要高的NaCl浓度来刺激菌体积累更多的产物,发酵周期较长,而且高浓度的氯化钠溶液对发酵设备腐蚀严重,不适合大规模的工业化生产,同时高盐的发酵废液对环境造成了较大压力;酶催化法生产四氢嘧啶的底物为天冬氨酸钠,酶需要诱导表达并提取,因此操作比较复杂,生产成本较高。严重制约了四氢嘧啶的工业化生产和大规模应用,因此、降低生产成本,对四氢嘧啶的应用有重要的实践意义。
目前发酵法或酶催化法生产肌肽的高磷高盐废水很难处理,使肌肽生产成本较高。枯草芽孢杆菌不受发酵法或酶催化法肌肽废水成分抑制,经诱变或基因重组可在低到中盐度的协迫下产生四氢嘧啶,使四氢嘧啶生产成本大大降低,同时也解决了肌肽的高磷高盐废水难处理问题。目前的枯草芽孢杆菌多用于α淀粉酶和中性蛋白酶工业生产,尚未发现将其用于工业生产四氢嘧啶的相关报道。
发明内容
有鉴于此,本发明的目的在于提供一种重组枯草芽孢杆菌在利用酶法合成肌肽的废水生产四氢嘧啶中的应用,使其能够利用酶法合成肌肽的废水生产四氢嘧啶;
本发明的另外一个目的在于提供利用上述重组枯草芽孢杆菌生产四氢嘧啶的方法。
为实现上述目的,本发明提供如下技术方案:
一种重组枯草芽孢杆菌,能够表达来源于嗜碱芽胞杆菌Bacillus alcalophilusDTY1的EctA、EctB和EctC。其中,EctA的蛋白序列如SEQ ID NO.1所示,EctB的蛋白序列如SEQ ID NO.2所示,EctC的蛋白序列如SEQ ID NO.3所示。
表达上述三个蛋白的编码基因可以是三个蛋白分别以独立的基因元件:启动子+EctA/B/C编码基因+终止子重组至枯草芽孢杆菌中进行表达,也可以以四氢嘧啶合成基因簇EctABC的编码基因方式一起表达,基因元件由启动子+EctA编码基因+间隔序列+EctB编码基因+间隔序列+EctC编码序列+终止子组成。作为优选,所述启动子为来源于嗜碱芽胞杆菌Bacillus alcalophilus DTY1的天然启动子(如SEQ ID NO.4所示1-812bp序列)、P43启动子或pHY300PLK载体上的启动子。
在本发明具体实施方式中,本发明提供了来源于嗜碱芽胞杆菌Bacillusalcalophilus DTY1的SEQ ID NO.4所示的四氢嘧啶合成基因簇EctABC编码基因,并将其重组到枯草芽孢杆菌工程菌中表达相关蛋白EctA、EctB和EctC,四氢嘧啶合成基因簇EctABC编码基因可以通过基因整合或者嵌合到载体上转化等方式实现表达或替换所需启动子。SEQ ID NO.4所示的四氢嘧啶合成酶的基因簇编码基因与常规方法中所用的序列不同,前端带有嗜碱芽胞杆菌(Bacillus alcalophilus DTY1)的天然启动子序列(1-812bp),能实现四氢嘧啶的表达强度随盐浓度增加而增加;813-1322bp为EctA编码基因,1404-2693bp为EctB编码基因,2761-3159bp为EctC编码基因,1323-1403bp以及2694-2760bp为各编码基因之间的间隔序列,3160-3856bp为终止子序列。
前述天然启动子对四氢嘧啶合成酶的表达有调控作用。当废水中盐的浓度达到一定的数量,启动子会启动四氢嘧啶合成酶的表达,并随盐度升高而调控EctABC表达升高。此外,本发明还可以用P43启动子代替原启动子,无需废水中盐浓度达到一定的数量才启动四氢嘧啶合成酶的表达;同时也用如pHY300PLK的市售载体搭载EctABC的编码基因转化到枯草芽孢杆菌中形成重组枯草芽孢杆菌。
为了进一步提高重组枯草芽孢杆菌生产四氢嘧啶的能力,所述重组枯草芽孢杆菌还包括使其无法表达四氢嘧啶跨膜转运蛋白OpuC,可以采用整个敲除OpuC编码基因的方法进行;为了尽量避免对OpuC基因簇下游其它基因的表达的影响,提高重组工程菌的稳定性,本发明优选通过GRISPR的方法在OpuC编码基因中引入终止密码子破坏其表达,具体通过在其每个单独基因(OpuCA、OpuCB、OpuCC、OpuCD)中间引入终止密码子(如TAA),从而破坏蛋白的正常表达。
更进一步地,所述重组枯草芽孢杆菌还无法表达中性蛋白酶nprE、碱性蛋白酶aprE、淀粉酶amyE和芽孢形成转录因子spo0A,这些相关酶或蛋白可以通过整段敲除编码基因来实现
将本发明所构建的重组枯草芽孢杆菌应用到酶法合成肌肽的废水中发酵,每吨废水可以得到四氢嘧啶8.5-35.6kg,菌渣蛋白饲料23.0-26.5kg,不仅能够得到较多的目标产物四氢嘧啶,而且同时得到副产物菌渣蛋白饲料,且排放的废水比原废水中COD、BOD、总磷、氨氮等下降70.4~96.2%。基于此,本发明提出了所述重组芽孢杆菌在以酶法合成肌肽的废水为原料生产四氢嘧啶中的应用。
依据应用,本发明还提供了一种利用酶法合成肌肽的废水生产四氢嘧啶的方法,包括:
步骤1、提供酶法合成肌肽的废水;
步骤2、将所述重组枯草芽孢杆菌接入所述废水中发酵,得到胞内含四氢嘧啶的发酵液,离心或板框压滤发酵液获取湿菌体;
步骤3、所述湿菌体破壁后经膜过滤,滤液利用阳离子交换树脂吸附四氢嘧啶,利用氨水洗脱四氢嘧啶;或
所述湿菌体用水搅拌洗涤,离心后上清液利用阳离子交换树脂吸附四氢嘧啶,利用氨水洗脱四氢嘧啶;或
所述湿菌体用乙醇浸提,浸提液回收乙醇后利用阳离子交换树脂吸附四氢嘧啶,利用氨水洗脱四氢嘧啶;
步骤4、洗脱后的四氢嘧啶经过精制得到四氢嘧啶成品。
作为优选,所述酶法合成肌肽的废水为利用微生物发酵生产L-氨基酸连接酶的酶液,催化肌肽合成原料合成肌肽工艺中产生的废水,包括L-氨基酸连接酶发酵废水和L-氨基酸连接酶反应纯化废水。
在本发明具体实施方式中,所述L-氨基酸连接酶发酵废水经由以下方法获得:
能够表达L-氨基酸连接酶的转基因微生物菌株发酵后的发酵液离心分离得菌体液和上清液;菌体液匀质破菌、膜过滤得菌体碎片;上清液和菌体碎片液合并作为酶的发酵废水。
在本发明具体实施方式中,所述L-氨基酸连接酶反应纯化废水经由以下方法获得:
肌肽合成原料(β-丙氨酸、L-组氨酸、ATP)加入L-氨基酸连接酶的酶液进行反应,反应完成后得到肌肽粗品溶液,依次经过膜分离、离子交换柱层析、结晶工艺进行纯化获得肌肽纯品,被膜分离和离子交换柱层析截留的废液作为酶反应纯化废水。
作为优选,所述发酵为在pH7.0、32℃、溶氧控制在20-30%条件下发酵18-36h;
作为优选,所述精制包括活性炭脱色、浓缩醇沉、重结晶、干燥等操作步骤;
作为优选,步骤3中离心后或膜过滤后或乙醇浸提后的菌渣可以干燥为蛋白饲料。
由以上技术方案可知,本发明通过基因工程技术构建一株重组枯草芽孢杆菌,其能够利用酶法合成肌肽的废水进行发酵,并得到含四氢嘧啶的发酵液。经提取不仅可获得较多的四氢嘧啶,同时得到副产物菌渣蛋白饲料,而且排放的废水比原废水中COD、BOD、总磷、氨氮等下降70.4~96.2%,该方法还具有操作简便,节省资源,安全环保,成本低等优点,适合工业推广应用。
附图说明
图1所示为质粒载体pHT-Cpf1图谱;
图2所示为质粒载体pHT-opuC-Cpf1图谱。
具体实施方式
本发明公开了重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法,本领域技术人员可以借鉴本文内容,适当改进工艺参数实现。特别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易见的,它们都被视为包括在本发明。本发明重组枯草芽孢杆菌及其应用和相关方法已经通过较佳实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和范围内对本文重组枯草芽孢杆菌及其应用和相关方法进行改动或适当变更与组合,来实现和应用本发明技术。
在本发明实施例中,酶法合成肌肽的废水的收集过程如下:
酶催化法肌肽的方法是以一定的培养基发酵L-氨基酸连接酶电转基因到大肠杆菌中,以LB培养基获得含胞内酶发酵液,发酵液离心分离得菌体液,菌体液匀质破菌、膜过滤得粗酶液。离心上清液和膜过滤菌体碎片液合并作为废水外排(其特性指标为COD31500mg/L、总磷2800mg/L、氨氮1386mg/L、BOD13000mg/L);肌肽原料(β-丙氨酸、L-组氨酸、ATP)反应液加入粗酶液进行反应,反应完成后得到反应液粗品溶液依次经过膜分离、离子交换柱层析、结晶工艺进行纯化获得纯品,反应液中的COD、总磷、氨氮、BOD等将被膜分离和离子交换柱层析各自部分截留并富集,截留的废液作为粗酶液催化肌肽反应纯化废水,其特性指标为COD14500mg/L、总磷3240mg/L、氨氮962mg/L、BOD10650mg/L、氯化钠7%。
上述两种废水合并(其特性指标为COD23000mg/L、总磷3020mg/L、氨氮1174mg/L、BOD13100mg/L、氯化钠3.5%)经杀菌接入本发明重组枯草芽孢杆菌在pH7.0、32℃、溶氧控制在20~30%条件下发酵18~36h,具体发酵条件可以根据实际情况调整,此处仅作示例性描述。
本发明中所涉及英文缩写含义参见下表1;
表1
Figure BDA0003241688550000061
除前述已记载的序列信息,本发明中所涉及的其他一些序列信息如下:
OpuCA蛋白序列:SEQ ID NO.5;
OpuCA编码序列:SEQ ID NO.6;
OpuCB蛋白序列:SEQ ID NO.7;
OpuCB编码序列:SEQ ID NO.8;
OpuCC蛋白序列:SEQ ID NO.9;
OpuCC编码序列:SEQ ID NO.10;
OpuCD蛋白序列:SEQ ID NO.11;
OpuCD编码序列:SEQ ID NO.12;
nprE蛋白序列:SEQ ID NO.13;
aprE蛋白序列:SEQ ID NO.14;
amyE蛋白序列:SEQ ID NO.15;
Spo0A蛋白序列:SEQ ID NO.16;
下面结合实施例,进一步阐述本发明。
实施例1:重组枯草芽孢杆菌的构建
1)扩增四氢嘧啶合成基因簇ectABC的编码序列
以嗜碱芽胞杆菌(Bacillus alcalophilus DTY1)的基因组DNA为模板,用针对四氢嘧啶合成基因簇EctABC编码基因设计引物EctABC-P1、EctABC-P2进行PCR扩增,得到PCR扩增产物。
EctABC-P1:5′-ATTAGTAAACAAATGACACTAG-3′
EctABC-P2:5′-TTACTACGTTTATTCTTCGC-3′
2)酶切、连接
用BamHI和SmaI双酶切PCR扩增产物,与预先使用BamH I和Sma I双酶切的pHY300PLK载体大片段进行连接,得到重组质粒。
3)转化、筛选以及序列验证
用热击的方法(Heat Shock)将上述制备的重组质粒转化至大肠杆菌DH5ɑ。阳性克隆记为DH5ɑ-pHY300PLK-EctABC。提取质粒,阳性质粒记为pHY300PLK-ectABC。通过基因测序确认序列正确。
4)重组表达菌株的构建
用电转染(Electroporation)的办法将重组质粒pHY300PLK-EctABC转入枯草芽孢杆菌ATCC6051(或者B.subtilis W800N),获得重组BS-pHY300PLK-EctABC。
5)细胞改造
用CRISPR/Cas12a的方法敲除重组BS-pHY300PLK-EctABC的转运蛋白OpuC、nprE(中性蛋白酶)、aprE(碱性蛋白酶)、amyE(淀粉酶)、spo0A(芽孢形成转录因子)等基因。
A.下面以GRISPR的方法引入终止码“TAA”改造OpuCA为例说明详细步骤,该示例性方法不应对本发明有限定作用:
以Bacillus subtilis ATCC6051a为例,其基因组中的OpuCA序列CDS如下:
>NC_020507.1:c3470982-3469840Bacillus subtilis subsp.subtilis6051-HGW,complete sequence;
①PAM识别基序的确定及crRNA的设计:将opuCA序列中位于259-261的三个碱基(TTG)确定为PAM识别位点,设计crRNA序列如下:
Oligo top:5’-TTTCCCCCATATGACCATCCAGCAGAGT-3’
Oligo bottom:5’-TCTGCTGGATGGTCATATGGGGGAAATC-3’
②构建pAC-crRNA表达载体
将以上两条寡聚链进行磷酸化和退火(同时进行),10μl反应体系如下:10X T4DNA ligase buffer 1μl;Oligo Top(100μM)1μl;Oligo Bottom(100μM)1μl;T4Polynucleotide Kinase(10U/μl)0.5μl;ddH2O 6.5μl。95℃孵育5min后,拿至室温自然降温到25℃左右,获得双链crRNA。
利用T4连接酶连接双链crRNA和经过Bpm I酶切的pAC质粒,经过热激转化E.coliTop10感受态细胞和阳性克隆子的菌落PCR鉴定以及测序鉴定,获得相应的pAC-crRNA(opuCA)表达载体。
③donor ssDNA的设计:
5’-T*G*AGGAGAAAAATCGGCTATGTGATACAGCAGATTGGTTAATTCCCCCATATGACCATCCAGCAGAACATCTCACTCGTACCAAAGC*T*G-3’,经Oligo合成获得donor ssDNA(opuCA)。
④BS-cpe01重组菌的获得:
将甘露醇诱导启动子PmtlA诱导cas12a表达的重组质粒pKD-cas12a-01热激转化至重组BS-pHY300PLK-EctABC菌中,30℃孵育24-36h,经菌落PCR及测序验证后,获得BS-cas12a-01-pHY300PLK-EctABC重组菌,命名为BS-cpe01。
⑤将100ng的pAC-crRNA(opuCA)和500ng donor ssDNA电转化至BS-cpe01电转感受态,电转条件为:电压2.1V,电容25u,电阻200Ω,电转后立即涂布于30℃预热的含相应抗生素和甘露醇的LB琼脂板中,30℃孵育24-36h,经菌落PCR验证,获得BS-cpe01opuCA重组菌。
⑥丢失BS-cpe01opuCA重组菌中的pAC-crRNA(opuCA)和pKD-cas12-01将重组单克隆置于100ul无抗LB中涂布于含相应抗生素和蔗糖的LB琼脂板,30℃孵育24-36h,挑转化子同时在无抗的和含有相应抗生素LB琼脂板上划线,只在无抗板上生长的克隆即为最终去除crRNA质粒的阳性克隆菌。将上述阳性克隆菌在42℃和相应蔗糖的LB培养条件培养,获得丢失pKD-cas12-01的重组菌落。
⑦通过提基因组和特异性引物的PCR扩增以及测序,最终获得△opuCA被终止表达菌株。
B.下面是GRISPR方法敲除目的基因详细步骤,该示例性方法不应对本发明有限定作用:
①PAM识别基序的确定及crRNA的设计:
请见下表中五个敲除基因序列中PAM识别位点,设计crRNA序列如下:
表2
Figure BDA0003241688550000091
②构建pHT-Cpf1载体质粒
利用SacI和BamHI限制性内切酶对质粒pHT01进行双酶切,获得6418bp和1538bp的两个片段,经1%的琼脂糖凝胶电泳分离后,切胶回收6418bp的片段。合成基因P43-FnCpf1,并利用Gibson
Figure BDA0003241688550000092
Cloning Kit同源重组至pHT01线性载体上,得到适用于Bacillus subtilis ATCC6051的CRISPR-FnCpf1载体质粒pHT-Cpf1(图谱见图1)。
③donor DNA的设计根据不同敲除目的基因的序列,位置。选择每个基因序列的上游750bp(RHA)),下游750bp(LHA).与crRNA一起构建可表达的crRNA和RHA,LHA基因片段。以opuC为例,具体设计为:Pveg-Direct repeat-opuC-crRNA-rrnB T1 terminator-opuC-RHA-LHA。此序列按顺序包含了以下基因元件:启动子,直接重复基因,目标基因中的crRNA,终止子,目标基因donor DNA(RHA-LHA)。
④构建pHT-opuC-Cpf1质粒:
以敲除opuC为例,具体实施步骤为:(1)利用BamHI限制性内切酶对质粒pHT-Cpf1进行单酶切,获得线性化的载体片段。(2)合成上一步③中基因片段。(3)利用Gibson
Figure BDA0003241688550000101
Cloning Kit将合成好的Pveg-Direct repeat-opuC-crRNA-rrnB T1terminator-opuC-RHA-LHA同源重组至pHT-Cpf1线性载体上,得到用于敲除Bacillussubtilis ATCC6051基因opuC的质粒pHT-opuC-Cpf1(图谱见图2)
⑤将表达FnCpf1和opuC-crRNA-opuC-RHA-LHA的重组质粒pHT-opuC-Cpf1热激转化至重组BS-pHT01-EctABC菌中,30℃孵育24-36h,经菌落PCR及测序验证后,获得BS-cas12a-01-opuC crRNA-pHT01-EctABC重组菌,命名为BS-cpe01opuCA重组菌。
⑥通过提基因组和特异性引物的PCR扩增以及测序验证,最终获得△opuCA敲除菌株。
⑦选择出丢失了pHT-opuC-Cpf1质粒的BS-cpe01opuCA重组菌。将重组单克隆接种到无抗LB培养液,37℃培养1-2小时后,培养液做分批稀释(1000倍-100倍-10倍)。取各稀释液到1000ul无抗LB中,37℃孵育24-36h。培养液在无抗LB琼脂板上划线,再次获得单克隆。然后挑单克隆同时在无抗的和含有相应抗生素(氨苄)的LB琼脂板上划线,只在无抗板上生长的克隆即为最终去除了pHT-opuC-Cpf1的质粒的阳性克隆菌。将上述阳性克隆菌保种,进行下一个敲除实验。
其它四个目标敲除基因按照同样的设计构建方法,在此不再赘述。
实施例2:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入该重组枯草芽孢杆菌(接入四氢嘧啶合成基因簇ectABC的重组质粒,从而在菌体细胞内产生四氢嘧啶)在pH7.0、32℃、溶氧控制在30%条件下发酵36h,得到胞内含四氢嘧啶的发酵液。该发酵液经蝶片离心机分离得菌体浆液和发酵上清液,菌体浆液经纯水搅拌洗涤在10~30min,菌体内四氢嘧啶释放到胞外,二次蝶片离心机分离,上清液利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。二次分离菌体浆液经板框压滤机过滤的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体8.6kg,菌渣蛋白饲料23.0kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为8250mg/L、702mg/L、288.9mg/L、76.1mg/L、3.14%,比原废水下降83.5%、94.6%、85.7%、93.5%、10.4%。
实施例3:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入该重组枯草芽孢杆菌(接入P43启动子和四氢嘧啶合成基因簇ectABC的重组质粒)在pH7.0、32℃、溶氧控制在30%条件下发酵36h,得到胞内含四氢嘧啶的发酵液。该发酵液经蝶片离心机分离得菌体浆液和发酵上清液,菌体浆液经均质机破壁后经陶瓷膜过滤去除菌体碎片、大部分蛋白和部分色素,膜过滤液利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。过滤的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体8.5kg,菌渣蛋白饲料23.4kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为6118mg/L、995.6mg/L、555.7mg/L、85.7mg/L、3.18%,比原废水下降73.4%、92.4%、81.6%、92.7%、9.2%。
实施例4:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入该重组枯草芽孢杆菌(接入pHY300PLK启动子和四氢嘧啶合成基因簇ectABC的重组质粒)在pH7.0、32℃、溶氧控制在30%条件下发酵36h,得到胞内含四氢嘧啶的发酵液。该发酵液经板框压滤机过滤去除发酵液中的部分蛋白和部分色素,得到的菌体滤渣用1:2乙醇分3次逆流溶胀浸提,使细胞中的四氢嘧啶物质达到最大限度的释放,从而获得高浓度的四氢嘧啶物质。浸提液减压回收乙醇再用。回收乙醇后浸提液利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。浸提后的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体8.9kg,菌渣蛋白饲料23.8kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为5106mg/L、720.5mg/L、510.4mg/L、62mg/L、3.11%,比原废水下降77.8%、94.5%、83.1%、94.7%、11.2%。
实施例5:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入重组枯草芽孢杆菌(接入P43启动子和四氢嘧啶合成基因簇ectABC的重组质粒,敲除敲除转运蛋白OpuC)在pH7.0、32℃、溶氧控制在30%条件下发酵36h,得到含四氢嘧啶的发酵液。该发酵液经板框压滤机过滤去除发酵液中的菌体、大部分蛋白和部分色素,然后利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。过滤的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体9.9kg,菌渣蛋白饲料24.2kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为6417mg/L、1362mg/L、703.7mg/L、100.9mg/L、3.17%,比原废水下降72.1%、89.6%、76.7%、91.4%、9.3%。
实施例6:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入重组枯草芽孢杆菌(接入P43启动子和四氢嘧啶合成基因簇ectABC的重组质粒,通过GRISPR的方法引入终止码“TAA”到OpuC基因簇中每个单独基因OpuCA,OpuCB,OpuCC,OpuCD中间,从而破坏蛋白的正常表达),在pH7.0、32℃、溶氧控制在30%条件下发酵36h,得到含四氢嘧啶的发酵液。该发酵液经板框压滤机过滤去除发酵液中的菌体、大部分蛋白和部分色素,然后利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。过滤的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体19.3kg,菌渣蛋白饲料23.0kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为5451mg/L、812.2mg/L、546.6mg/L、115.1mg/L、3.12%,比原废水下降76.3%、93.8%、81.9%、90.2%、10.8%。
实施例7:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入重组枯草芽孢杆菌(接入pHY300PLK启动子和四氢嘧啶合成基因簇ectABC的重组质粒,通过GRISPR的方法引入终止码“TAA”到OpuC基因簇中每个单独基因OpuCA,OpuCB,OpuCC,OpuCD中间,从而破坏蛋白的正常表达),在pH7.0、32℃、溶氧控制在30%条件下发酵36h,发酵中当碳源不足时适当补加碳源,充分利用各组分,得到含四氢嘧啶更多的发酵液。该发酵液经板框压滤机过滤去除发酵液中的菌体、大部分蛋白和部分色素,然后利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。过滤的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体21.4kg,菌渣蛋白饲料26.5kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为6808mg/L、1244.5mg/L、655.3mg/L、113.9mg/L、3.16%,比原废水下降70.4%、90.5%、78.3%、90.3%、9.6%。
实施例8:酶催化法合成肌肽的废水生产四氢嘧啶
将酶法合成肌肽的发酵废水和酶反应纯化废水合并,经巴氏杀菌接入重组枯草芽孢杆菌(接入P43启动子和四氢嘧啶合成基因簇ectABC的重组质粒,通过GRISPR的方法引入终止码“TAA”到OpuC基因簇中每个单独基因OpuCA,OpuCB,OpuCC,OpuCD中间,从而破坏蛋白的正常表达,直接敲除nprE、aprE、amyE、spoIIAC的编码基因),在pH7.0、32℃、溶氧控制在30%条件下发酵36h,发酵中当碳源不足时适当补加碳源,充分利用各组分,得到含四氢嘧啶更多的发酵液。该发酵液经板框压滤机过滤去除发酵液中的菌体、大部分蛋白和部分色素,然后利用阳离子交换树脂吸附四氢嘧啶,再用氨水将四氢嘧啶洗脱后,经过活性炭脱色、浓缩醇沉、重结晶、干燥成品等操作步骤得到四氢嘧啶产品。过滤的菌渣干燥得蛋白饲料。每吨废水得到四氢嘧啶白色固体35.6kg,菌渣蛋白饲料25.2kg。排放的废水中COD、BOD、总磷、氨氮、氯化钠分别为3818mg/L、851.5mg/L、486.2mg/L、68.1mg/L、3.05%,比原废水下降83.4%、93.5%、83.9%、96.2%、12.7%。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
序列表
<110> 珠海瑞德林生物有限公司
<120> 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法
<130> S21P001367
<160> 16
<170> SIPOSequenceListing 1.0
<210> 1
<211> 169
<212> PRT
<213> Bacillus alcalophilus DTY1
<400> 1
Met Thr Leu Ala Pro Thr Lys Gln Thr Glu Ser Ile Leu Phe Thr Gln
1 5 10 15
Pro Thr Lys Gln Asp Gly Ala Asp Met Trp Asn Leu Val Asn Glu Thr
20 25 30
Ser Leu Asp Gln Asn Ser Ala Tyr Lys Tyr Ile Met Met Ser Glu Phe
35 40 45
Phe Ala Asp Thr Cys Ile Val Ala Lys Arg Gly His Glu Leu Val Gly
50 55 60
Phe Val Thr Ala Phe Arg Pro Pro Asn Arg Gln Asp Ala Leu Phe Ile
65 70 75 80
Trp Gln Ile Gly Val Lys Pro Ser Glu Gln Gly Asn Gly Ile Ala Ser
85 90 95
Gln Leu Leu Gln Glu Met Leu Lys Arg Asp His Asn Pro Ala Ile Asn
100 105 110
Tyr Val Glu Ala Thr Ile Thr Pro Ser Asn Gly Ala Ser Gln Ala Leu
115 120 125
Phe Lys Lys Leu Ala Arg Asp Leu Asn Thr Glu Cys Val Ser Glu Arg
130 135 140
Phe Phe Thr Glu Glu Leu Phe Pro Gly Asp Thr His Glu Glu Glu Leu
145 150 155 160
Met Phe Arg Ile Gly Pro Leu Ser Ser
165
<210> 2
<211> 428
<212> PRT
<213> Bacillus alcalophilus DTY1
<400> 2
Met Thr Gln Thr Asp Met Ser Ile Phe Glu Gln Met Glu Ser Glu Val
1 5 10 15
Arg Ser Tyr Cys Arg Ser Phe Pro Thr Val Phe Ser Lys Ala Ile Gly
20 25 30
Ser Lys Met Trp Asp Glu Ala Gly Lys Glu Tyr Ile Asp Phe Phe Ser
35 40 45
Gly Ala Gly Ala Leu Asn Tyr Gly His Asn Asp Pro Ala Met Lys Ala
50 55 60
Lys Leu Val Asp Tyr Ile Leu Ser Asp Gly Met Thr His Ser Leu Asp
65 70 75 80
Met Ala Thr Thr Ala Lys Ala Glu Phe Leu Gln Ser Phe Asn Asp Ile
85 90 95
Ile Leu Lys Pro Arg Asn Leu Asp Tyr Lys Val Met Phe Pro Gly Pro
100 105 110
Thr Gly Thr Asn Thr Val Glu Ser Ala Leu Lys Leu Ala Arg Lys Ser
115 120 125
Thr Gly Arg Thr Asp Ile Ile Ser Phe Thr Asn Gly Phe His Gly Met
130 135 140
Thr Ile Gly Ser Leu Ser Val Thr Gly Asn Ser Phe Lys Arg Lys Gly
145 150 155 160
Ala Gly Ile Pro Leu His Asn Val Val Thr Met Pro Tyr Asp Ser Phe
165 170 175
Val Ser Glu Lys Leu Asp Thr Leu Glu Tyr Leu Glu Arg Phe Leu Glu
180 185 190
Asp Arg Gly Ser Gly Val Ala Ile Pro Ala Ala Met Ile Leu Glu Thr
195 200 205
Val Gln Gly Glu Gly Gly Ile Asn Ala Ala Ser Phe Glu Trp Leu Gln
210 215 220
Arg Ile Glu Arg Thr Cys Lys Arg Trp Gly Ile Leu Leu Ile Val Asp
225 230 235 240
Asp Val Gln Ala Gly Val Gly Arg Thr Arg Thr Phe Phe Ser Phe Glu
245 250 255
Lys Ala Gly Ile Lys Pro Asp Ile Val Cys Ile Ser Lys Ser Ile Gly
260 265 270
Gly Tyr Gly Leu Pro Leu Ala Leu Thr Leu Ile Arg Pro Glu Leu Asp
275 280 285
Ile Trp Ala Pro Gly Glu His Asn Gly Thr Phe Arg Gly Asn Asn His
290 295 300
Ala Phe Val Thr Ala Thr Ala Ala Leu Ala Tyr Trp Glu Asn Pro Thr
305 310 315 320
Phe Glu Lys Ser Ile Ala Asp Lys Ser Lys Lys Ile Lys Ser Phe Leu
325 330 335
Glu Lys Ile Val Glu Asp Tyr Pro Glu Ile Lys Gly Glu Val Arg Gly
340 345 350
Arg Gly Phe Met Ile Gly Ile Ala Ser Glu Val Lys Asp Leu Ser Ala
355 360 365
Gln Val Ala Lys Glu Ala Phe Lys Arg Gly Leu Ile Met Glu Thr Ser
370 375 380
Gly Pro Glu Asp Glu Val Phe Lys Leu Phe Pro Ala Leu Thr Ile Asp
385 390 395 400
Asn Glu Thr Leu Glu Lys Gly Phe Asp Val Ile Glu Glu Ser Val Lys
405 410 415
Ala Val Val Gly Ser Lys Glu Pro Met Thr Val Ser
420 425
<210> 3
<211> 132
<212> PRT
<213> Bacillus alcalophilus DTY1
<400> 3
Met Lys Val Val Ala Leu Lys Asp Val Ile Gly Thr Glu His Asp Val
1 5 10 15
Lys Asn Glu Asp Asn Thr Trp Asn Ser Arg Arg Leu Val Leu Lys Lys
20 25 30
Asp Gly Met Gly Tyr Ser Val His Asp Thr Ile Ile Tyr Ala Gly Thr
35 40 45
Glu Thr His Ile Trp Tyr Gln Asn His Leu Glu Ser Val Tyr Cys Ile
50 55 60
Glu Gly Glu Gly Glu Val Glu Thr Ile Ala Asp Gly Lys Val Trp Pro
65 70 75 80
Ile Lys Lys Asp Glu Ile Tyr Val Leu Asp Lys His Asp Glu His Leu
85 90 95
Leu Arg Ala Lys Thr Asp Met Arg Met Val Cys Val Phe Asn Pro Pro
100 105 110
Ile Thr Gly Asn Glu Val His Asp Glu Asn Gly Val Tyr Pro Val Asp
115 120 125
Thr Ser Glu Glu
130
<210> 4
<211> 3856
<212> DNA
<213> Bacillus alcalophilus DTY1
<400> 4
tagatgtatc ttccatgaaa gggggcagct aaatttatgg ccagcaaaaa aaagacagca 60
ccagacgaaa gaagaacttt acggaaagcg caagaagttc aatatcaatc tgaatttcgc 120
gcagctgaca gagccgcacg ttcgcagtca aaaggagttt aaaacattcc cttcactttt 180
acttgctgtc catcttaaag tcacgttagc ttacaactag agctagacta ctttacacct 240
ttaacaagga ggctgttcac tttgggtaaa aaggaaaaac gcatgcaacc taacaagcaa 300
agtacagaaa ccattgatac cgaaatcgct aatgaatatg ctgatgtatc gaaagagcaa 360
ccaacatcta agaagaaaaa gaagaaaaac cattcataat aggattgcca tgagatatag 420
gtataaagcc tatatctctt ttttatgaat aaaattgttt atattatggt caatttgtca 480
aatcgtcagc ttttatgacc tttgttatac gttccatttc cttaaattag ggcttcttta 540
tgtttcaagc tttcaaaatc atcgctttat ttcaatttgt tagaaaagtt aacgatatgg 600
aaggatatac agctatcgtt gctcttattc ccggtcaccg ttgctaagcc tattagaagc 660
cacttaatcc gcgcataact catttgcacc ttttttcgta tccccttaag ataaatatgt 720
ggtttagaaa aatcactgat gggtatgtaa acaattgtga ataacttttg cccagaaagt 780
ctacaaagga ggaaaaaacc attagtaaac aaatgacact agcacctact aagcaaactg 840
aatccatttt attcacgcaa ccaacgaagc aagatggtgc agacatgtgg aatcttgtca 900
atgaaacatc gctcgatcaa aactctgctt ataagtacat tatgatgtca gaattttttg 960
ccgacacatg tatcgtggct aaacgcggtc atgagctcgt cggatttgtt acagcatttc 1020
gtccacctaa tcgccaagat gccctattta tttggcaaat tggtgtcaaa ccttccgaac 1080
aaggtaatgg gattgcctcg cagcttttac aagaaatgct taagcgtgat cacaatccag 1140
cgattaacta tgtagaagca acgataaccc catctaacgg agcatcgcaa gctctattta 1200
aaaagttagc cagagactta aataccgaat gtgtaagtga acgattcttt acagaagaat 1260
tgtttcctgg cgatacccat gaagaagaac tcatgtttcg aattggtcca ttatcgtctt 1320
aacatagtca acccttgagt ttgcacaaca acttaaatac ctatacagag tataagtata 1380
ttattcggga ggagaacgta aacatgacac aaactgatat gagtattttt gaacaaatgg 1440
aatccgaggt tcgtagttat tgtcgcagct ttccaactgt tttttcaaaa gcgattgggt 1500
caaaaatgtg ggatgaagct gggaaggaat atattgattt cttttcaggt gcaggtgctt 1560
taaattatgg ccataatgat cctgcgatga aagccaagct cgttgattat attttgtcag 1620
atgggatgac gcattcactt gatatggcaa caactgccaa ggcagagttt ttgcaatcat 1680
ttaatgatat tattttaaaa ccacgtaatt tagattataa agtaatgttt ccgggaccaa 1740
ctggaacaaa tacggtggaa agtgccctta aattagctcg aaaatcaaca ggtcgtacag 1800
atatcattag cttcacaaac ggctttcatg gaatgacgat cggatcgctt tctgtaacag 1860
gtaattcatt taaacgaaaa ggagctggaa tcccactcca taatgttgtg acaatgcctt 1920
atgatagctt cgttagtgaa aaactcgaca ctctggagta tctcgaacgt ttcttagaag 1980
atcgcggaag cggggtcgcc atcccggctg ccatgatcct cgagacagtc caaggtgaag 2040
gtggtataaa tgccgcaagc ttcgagtggc tacaacgaat tgagcggact tgtaagcgtt 2100
ggggaatttt attaatcgtt gatgatgttc aagcaggtgt tggccgaact cgtactttct 2160
tcagttttga aaaagctggc attaaaccag atatcgtctg tatttcaaaa tcaatcggtg 2220
gctatggtct tccattagct ttaacactca ttcgtcctga gcttgatatt tgggcgcctg 2280
gtgaacataa tggaacattc cgtggaaaca accatgcgtt cgtaacagca accgctgccc 2340
ttgcttattg ggaaaatcca acatttgaaa aaagcatcgc cgataaatca aagaaaatta 2400
aatcattcct cgaaaaaatc gttgaagatt atccagaaat aaaaggagaa gttcgaggac 2460
gcggatttat gatcggcatc gcttctgaag tgaaggacct ttcggctcaa gttgccaaag 2520
aagcttttaa acgtggctta attatggaaa catctggtcc agaagatgaa gtctttaaat 2580
tatttcctgc attaacgatt gacaacgaaa cacttgaaaa aggattcgat gtaattgaag 2640
aaagtgtaaa agcagttgtt ggctcaaaag aacctatgac cgtttcttaa tcatactaca 2700
ctcttctaca cgcgcatccg ttacaccatt attcacaaac tatttggagg ttttataatc 2760
atgaaagtcg ttgccctaaa agatgttatt ggaacagaac atgacgtaaa aaatgaagat 2820
aatacatgga acagtcgtcg tctcgtcttg aaaaaagacg gcatgggcta ttccgtccat 2880
gatacgatta tttatgctgg tacggaaact catatttggt atcaaaacca tcttgagtcg 2940
gtttattgta tcgaaggtga aggtgaagtc gaaacgattg ccgacggaaa agtatggcca 3000
attaaaaaag acgaaatata tgttttagat aaacatgatg agcatctatt acgtgctaaa 3060
actgatatga gaatggtttg cgtctttaat ccgccaatca ctggaaacga agtccatgat 3120
gaaaatggcg tttatcccgt tgatacaagc gaagaataaa cgtagtaaaa catataaacc 3180
gctatcttct cttttcagaa agagaggata gcggttttat tatacgtgtt tacccgattc 3240
cctgctcata agtcgaaata attgcacccc ataaaaaggg gtgttgcgca tgacgaaaag 3300
gataggcttc ggcgatccgc gatcgctccc aaacagacac tccgcgtcct acggggtcct 3360
tgtgagcccc ctcggcacac ctgtggggtc tcactctacg gacttttccc gtgggagtct 3420
ccgtgtctgt ttgtccgctt agttgtgagt tatacttcat ttctcattcc ttttataata 3480
aaagacatta aaatctccaa ccttttttag tagctgcatt ttacctactg agcgggctca 3540
aaactcaatt acagggattc gatataacta tcagcgagct taaatgttat aagaaacgat 3600
tgtaaggcat tgaggtaaaa caaagtggta cattgttttt agtaaccata gatttgaaca 3660
atcaacaact actttgacaa tgacaagcga atatacgact gttttcatta ttttgaaggg 3720
gactacatta taaaataacg ctcaaactct agcgtacaaa accatacgga gactcccgcg 3780
gaaataaacc gaggagcgag accccacagg gataccgagg aggctcgcca ggtttccgca 3840
ggacgcggag tatggt 3856
<210> 5
<211> 380
<212> PRT
<213> ATCC6051
<400> 5
Met Leu Lys Leu Glu Gln Val Ser Lys Val Tyr Lys Gly Gly Lys Lys
1 5 10 15
Ala Val Asn Ser Ile Asp Leu Asp Ile Ala Lys Gly Glu Phe Ile Cys
20 25 30
Phe Ile Gly Pro Ser Gly Cys Gly Lys Thr Thr Thr Met Lys Met Ile
35 40 45
Asn Arg Leu Ile Glu Pro Ser Ser Gly Arg Ile Phe Ile Asp Gly Glu
50 55 60
Asn Ile Met Glu Gln Asp Pro Val Glu Leu Arg Arg Lys Ile Gly Tyr
65 70 75 80
Val Ile Gln Gln Ile Gly Leu Phe Pro His Met Thr Ile Gln Gln Asn
85 90 95
Ile Ser Leu Val Pro Lys Leu Leu Lys Trp Pro Glu Glu Lys Arg Lys
100 105 110
Glu Arg Ala Arg Glu Leu Leu Lys Leu Val Asp Met Gly Pro Glu Tyr
115 120 125
Leu Asp Arg Tyr Pro His Glu Leu Ser Gly Gly Gln Gln Gln Arg Ile
130 135 140
Gly Val Leu Arg Ala Leu Ala Ala Glu Pro Pro Leu Ile Leu Met Asp
145 150 155 160
Glu Pro Phe Gly Ala Leu Asp Pro Ile Thr Arg Asp Ser Leu Gln Glu
165 170 175
Glu Phe Lys Lys Leu Gln Arg Thr Leu Asn Lys Thr Ile Val Phe Val
180 185 190
Thr His Asp Met Asp Glu Ala Ile Lys Leu Ala Asp Arg Ile Val Ile
195 200 205
Leu Lys Ala Gly Glu Ile Val Gln Val Gly Thr Pro Asp Glu Ile Leu
210 215 220
Arg Asn Pro Ala Asn Glu Phe Val Glu Glu Phe Ile Gly Lys Glu Arg
225 230 235 240
Leu Ile Gln Ser Arg Pro Asp Ile Glu Arg Val Glu Gln Met Met Asn
245 250 255
Arg Thr Pro Val Thr Val Ser Ala Asp Lys Thr Leu Ser Gln Ala Ile
260 265 270
Gln Leu Met Arg Glu Lys Arg Val Asp Ser Leu Leu Val Val Asp Arg
275 280 285
Gln Asn Val Leu Lys Asp Tyr Val Asp Val Glu Met Ile Asp Gln Asn
290 295 300
Arg Lys Lys Ala Ser Ile Val Gly Asp Val Tyr Arg Ser Asp Ile Tyr
305 310 315 320
Thr Val Gln Lys Gly Ala Leu Leu Arg Asp Thr Val Arg Lys Ile Leu
325 330 335
Lys Gln Gly Ile Lys Tyr Val Pro Val Val Asp Glu Gln Asn His Leu
340 345 350
Ala Gly Ile Val Thr Arg Ala Ser Leu Val Asp Ile Val Tyr Asp Ser
355 360 365
Ile Trp Gly Asp Glu Glu Asn Gln Leu Met Thr Ile
370 375 380
<210> 6
<211> 1143
<212> DNA
<213> ATCC6051
<400> 6
ttgctgaaat tggaacaagt gtcaaaagta tataaaggcg gcaaaaaagc tgtgaacagc 60
attgatttag atattgccaa aggtgaattt atctgtttta tcggcccgag cggctgtgga 120
aaaacgacga cgatgaagat gatcaacagg ctgatagaac catcgtctgg aaggatcttt 180
atcgacggag aaaatattat ggaacaggac ccggttgagc tgaggagaaa aatcggctat 240
gtaattcagc agattggttt gttcccccat atgaccatcc agcagaacat ctcactcgta 300
ccaaagctgc tgaaatggcc tgaggaaaaa cggaaagaac gggcgcgcga gctgttaaag 360
cttgtggata tgggcccaga gtatttagac cgttatccgc atgagctcag cggcggacag 420
cagcagagaa tcggcgtgct gcgcgcactg gcagcggaac cccctctcat tttaatggat 480
gaaccgttcg gagcgcttga tccgattacg cgtgattccc ttcaggaaga attcaaaaaa 540
ctgcagagaa ccttaaacaa aacgattgtg tttgtaaccc acgatatgga tgaagcgatt 600
aagcttgctg acaggattgt gatattaaaa gcgggagaaa tcgttcaagt cggcacacct 660
gatgagattc ttcgaaaccc ggcaaatgag tttgttgaag aatttatcgg gaaagagcgc 720
ctgattcagt caagaccgga tatcgagcgg gtagagcaaa tgatgaacag aacgccggtg 780
acggtatctg cggacaaaac gctttctcag gcgattcagc tgatgagaga aaaacgtgtt 840
gactcgctgc tcgttgtgga ccggcaaaac gtgctgaagg actatgttga tgtggaaatg 900
attgatcaaa accgcaaaaa agcgagcatc gttggcgacg tataccgttc agatatatat 960
accgttcaaa aaggggcgct tcttcgcgat acagtccgaa aaattttgaa gcaggggatc 1020
aagtatgttc cggtggtcga tgaacagaac catttagcag ggattgtgac aagagcgagc 1080
ctcgttgata tcgtatacga ttccatttgg ggcgacgagg aaaatcagct catgacgatc 1140
tga 1143
<210> 7
<211> 217
<212> PRT
<213> ATCC6051
<400> 7
Met Asn Gln Met Met Thr Phe Leu Gln Thr Asn Gly Gly Glu Leu Leu
1 5 10 15
Tyr Lys Thr Gly Glu His Leu Tyr Ile Ser Leu Ile Ala Val Val Leu
20 25 30
Gly Ile Ile Val Ala Val Pro Leu Gly Val Ala Leu Thr Arg Met Lys
35 40 45
Lys Gly Ala Gly Ala Val Ile Gly Phe Val Asn Ile Val Gln Thr Leu
50 55 60
Pro Ser Leu Ala Ile Leu Ala Phe Phe Ile Pro Leu Leu Gly Val Gly
65 70 75 80
Lys Val Pro Ala Ile Val Ala Leu Phe Phe Tyr Ser Val Leu Pro Ile
85 90 95
Leu Arg Asn Thr Tyr Thr Gly Ile Lys Gly Val Asn Lys Asn Leu Leu
100 105 110
Glu Ser Gly Lys Gly Ile Gly Met Thr Gly Trp Glu Gln Ile Arg Leu
115 120 125
Val Glu Ile Pro Leu Ala Ile Pro Ile Ile Met Ala Gly Ile Arg Thr
130 135 140
Ser Thr Ile Tyr Leu Ile Gly Trp Ala Thr Leu Ala Ser Phe Ile Gly
145 150 155 160
Gly Gly Gly Leu Gly Asp Tyr Ile Phe Ile Gly Leu Asn Leu Tyr Gln
165 170 175
Pro Glu Tyr Ile Ile Gly Gly Ala Val Pro Val Thr Ile Leu Ala Ile
180 185 190
Ile Ile Asp Tyr Val Leu Ala Val Thr Glu Arg Lys Val Thr Pro Lys
195 200 205
Gly Leu Gln Gly Met Lys Glu Val Ser
210 215
<210> 8
<211> 654
<212> DNA
<213> ATCC6051
<400> 8
atgaatcaaa tgatgacttt tttgcaaacg aacggcggag agctgctgta taaaacagga 60
gagcatttat atatttcact catagccgtt gtattgggca ttatcgttgc agtgccgctt 120
ggcgttgctc tcaccagaat gaaaaaaggc gcaggtgcgg ttatcggttt cgtaaacatt 180
gtgcaaaccc tgccgagtct ggcgatttta gcctttttta ttccgcttct cggcgtagga 240
aaagtgcctg cgattgtcgc tttatttttc tattcggtgc tgccgatcct gcgcaatacg 300
tataccggca ttaaaggtgt aaataaaaac ctgctggaat cggggaaagg gattggcatg 360
accggctggg agcagattcg gctcgttgaa atcccgctgg cgattcccat catcatggcg 420
gggatccgca catcaacgat ctacctaatt ggctgggcga cacttgcgtc gtttatcggg 480
ggaggcggcc tcggggacta tatttttatc ggcctgaacc tataccagcc tgaatatatc 540
attggcggtg ccgtgcctgt cacaattctg gcaattatta ttgattatgt cctggccgtg 600
acagaacgaa aggtgacgcc gaaaggcttg caagggatga aggaagtttc gtaa 654
<210> 9
<211> 305
<212> PRT
<213> ATCC6051
<400> 9
Met Lys Met Thr Lys Ile Lys Trp Leu Gly Ala Phe Ala Leu Val Phe
1 5 10 15
Val Met Leu Leu Gly Gly Cys Ser Leu Pro Gly Leu Gly Gly Ala Ser
20 25 30
Asp Asp Thr Ile Lys Ile Gly Ala Gln Ser Met Thr Glu Ser Glu Ile
35 40 45
Val Ala Asn Met Ile Ala Gln Leu Ile Glu His Asp Thr Asp Leu Asn
50 55 60
Thr Ala Leu Val Lys Asn Leu Gly Ser Asn Tyr Val Gln His Gln Ala
65 70 75 80
Met Leu Gly Gly Asp Ile Asp Ile Ser Ala Thr Arg Tyr Ser Gly Thr
85 90 95
Asp Leu Thr Ser Thr Leu Gly Lys Glu Ala Glu Lys Asp Pro Lys Lys
100 105 110
Ala Leu Asn Ile Val Gln Asn Glu Phe Gln Lys Arg Phe Ser Tyr Lys
115 120 125
Trp Phe Asp Ser Tyr Gly Phe Asp Asn Thr Tyr Ala Phe Thr Val Thr
130 135 140
Lys Lys Phe Ala Glu Lys Glu His Ile Asn Thr Val Ser Asp Leu Lys
145 150 155 160
Lys Asn Ala Ser Gln Tyr Lys Leu Gly Val Asp Asn Ala Trp Leu Lys
165 170 175
Arg Lys Gly Asp Gly Tyr Lys Gly Phe Val Ser Thr Tyr Gly Phe Glu
180 185 190
Phe Gly Thr Thr Tyr Pro Met Gln Ile Gly Leu Val Tyr Asp Ala Val
195 200 205
Lys Asn Gly Lys Met Asp Ala Val Leu Ala Tyr Ser Thr Asp Gly Arg
210 215 220
Ile Lys Ala Tyr Asp Leu Lys Ile Leu Lys Asp Asp Lys Arg Phe Phe
225 230 235 240
Pro Pro Tyr Asp Cys Ser Pro Val Ile Pro Glu Lys Val Leu Lys Ala
245 250 255
His Pro Glu Leu Glu Gly Val Ile Asn Lys Leu Ile Gly Gln Ile Asp
260 265 270
Thr Glu Thr Met Gln Glu Leu Asn Tyr Glu Val Asp Gly Lys Leu Lys
275 280 285
Glu Pro Ser Val Val Ala Lys Glu Phe Leu Glu Lys His His Tyr Phe
290 295 300
Asp
305
<210> 10
<211> 918
<212> DNA
<213> ATCC6051
<400> 10
ttgaaaatga caaaaatcaa atggcttggc gcgtttgctc tcgtctttgt catgctgcta 60
ggcggctgct ctctgccggg tctcggcggc gcttctgacg acacgatcaa aatcggggcg 120
cagagcatga cagaatcaga aattgtagcg aatatgatcg cgcagcttat tgaacacgat 180
acagatttga ataccgcttt agtgaaaaac ctcggctcaa actatgttca gcaccaagcg 240
atgctgggcg gtgacattga tatttcagcc acgcgctatt ccggaacaga tttaacaagc 300
accctcggca aggaagcgga gaaagatccg aaaaaagcgc tgaacattgt gcagaatgag 360
tttcaaaagc gcttttctta taaatggttt gattcctacg gctttgataa cacatatgcc 420
ttcaccgtaa caaaaaaatt tgcggaaaag gagcatatta acaccgtgtc cgacctgaaa 480
aaaaatgcct cccaatataa attaggcgtc gacaatgctt ggctgaaacg aaaaggcgac 540
gggtataaag gctttgtcag cacatatggc tttgaattcg gcacaactta tccaatgcag 600
atcgggcttg tctatgacgc agtcaaaaac gggaaaatgg acgccgttct ggcttattca 660
acggatggac ggattaaagc ctatgacttg aaaatcttaa aagatgataa gcgtttcttt 720
ccgccgtatg actgttcacc ggtgattccg gaaaaggtgc ttaaggcgca tccggagctt 780
gagggtgtga tcaataagct gattgggcaa atcgacacgg aaacgatgca ggaacttaat 840
tatgaagtgg atggcaagct gaaggagccg tctgtcgtag caaaggaatt tttagagaaa 900
catcattatt ttgactaa 918
<210> 11
<211> 224
<212> PRT
<213> ATCC6051
<400> 11
Met Glu Val Leu Gln Gln Leu Gly Thr Tyr Tyr Ser Gln Asn Gly Gly
1 5 10 15
Tyr Val Leu Gln Glu Phe Cys Arg His Phe Leu Met Ser Val Tyr Gly
20 25 30
Val Leu Phe Ala Ala Ile Val Gly Ile Pro Leu Gly Ile Leu Ile Ala
35 40 45
Arg Tyr Arg Arg Leu Ser Gly Trp Val Phe Ala Val Thr Asn Val Ile
50 55 60
Gln Thr Ile Pro Ala Leu Ala Met Leu Ala Val Leu Met Leu Val Met
65 70 75 80
Gly Leu Gly Ala Asn Thr Val Ile Leu Ser Leu Phe Leu Tyr Ser Leu
85 90 95
Leu Pro Ile Ile Arg Asn Thr Tyr Thr Gly Ile Ile Ser Ile Glu His
100 105 110
Ala Tyr Leu Glu Ser Gly Lys Ala Met Gly Met Thr Lys Phe Gln Val
115 120 125
Leu Arg Met Val Glu Leu Pro Leu Ala Leu Ser Val Ile Met Ala Gly
130 135 140
Leu Arg Thr Ala Leu Val Ile Ala Ile Gly Ile Thr Ala Ile Gly Thr
145 150 155 160
Phe Val Gly Ala Gly Gly Leu Gly Asp Ile Ile Val Arg Gly Ser Asn
165 170 175
Ala Thr Asn Gly Thr Ala Ile Ile Leu Ala Gly Ala Ile Pro Thr Ala
180 185 190
Leu Met Ala Val Ile Ala Asp Leu Val Met Gly Trp Leu Glu Arg Ala
195 200 205
Leu Ser Pro Ile Lys Lys Arg Lys Lys Lys Asn Leu Ala Gly Ala Ala
210 215 220
<210> 12
<211> 675
<212> DNA
<213> ATCC6051
<400> 12
atggaagtac tacagcagct tggcacatac tattcgcaaa acggcggtta tgtgctgcag 60
gagttttgcc gccattttct gatgtcggtg tacggcgttt tatttgccgc cattgttgga 120
attccgctcg gcatcctgat agccagatac agaagattaa gcggatgggt ttttgcggtc 180
acgaacgtca ttcagaccat cccggctctc gccatgctcg ccgtgctgat gcttgtcatg 240
gggctgggcg ctaatacggt gatattgtca ttatttctgt attctcttct gccgattatc 300
agaaatacgt atactgggat tatcagtatt gagcacgcct atcttgaatc cggaaaagca 360
atggggatga caaaatttca agtgctgcgg atggtcgagc ttccgcttgc gctttcggtc 420
ataatggccg gcctgcgcac cgcgcttgtc attgccatcg gcattacggc catcgggaca 480
tttgtcggtg ctggcggtct cggggatatc atcgtcaggg gatcaaacgc cacaaacgga 540
accgcaatta tattagcggg agcgatcccc acagctctga tggcggtgat tgccgatttg 600
gtcatgggtt ggcttgaacg agcgttaagc ccgattaaaa agagaaagaa gaaaaacttg 660
gcaggtgccg cataa 675
<210> 13
<211> 521
<212> PRT
<213> ATCC6051
<400> 13
Met Gly Leu Gly Lys Lys Leu Ser Val Ala Val Ala Ala Ser Phe Met
1 5 10 15
Ser Leu Ser Ile Ser Leu Pro Gly Val Gln Ala Ala Glu Gly His Gln
20 25 30
Leu Lys Glu Asn Gln Thr Asn Phe Leu Ser Lys Asn Ala Ile Ala Gln
35 40 45
Ser Glu Leu Ser Ala Pro Asn Asp Lys Ala Val Lys Gln Phe Leu Lys
50 55 60
Lys Asn Ser Asn Ile Phe Lys Gly Asp Pro Ser Lys Arg Leu Lys Leu
65 70 75 80
Val Glu Ser Thr Thr Asp Ala Leu Gly Tyr Lys His Phe Arg Tyr Ala
85 90 95
Pro Val Val Asn Gly Val Pro Ile Lys Asp Ser Gln Val Ile Val His
100 105 110
Val Asp Lys Ser Asp Asn Val Tyr Ala Val Asn Gly Glu Leu His Asn
115 120 125
Gln Ser Ala Ala Lys Thr Asp Asn Ser Gln Lys Val Ser Ser Glu Lys
130 135 140
Ala Leu Ala Leu Ala Phe Lys Ala Ile Gly Lys Ser Pro Asp Ala Val
145 150 155 160
Ser Asn Gly Ala Ala Lys Asn Ser Asn Lys Ala Glu Leu Lys Ala Ile
165 170 175
Glu Thr Lys Asp Gly Ser Tyr Arg Leu Ala Tyr Asp Val Thr Ile Arg
180 185 190
Tyr Val Glu Pro Glu Pro Ala Asn Trp Glu Val Leu Val Asp Ala Glu
195 200 205
Thr Gly Ser Ile Leu Lys Gln Gln Asn Lys Val Glu His Ala Ala Ala
210 215 220
Thr Gly Ser Gly Thr Thr Leu Lys Gly Ala Thr Val Pro Leu Asn Ile
225 230 235 240
Ser Tyr Glu Gly Gly Lys Tyr Val Leu Arg Asp Leu Ser Lys Pro Thr
245 250 255
Gly Thr Gln Ile Ile Thr Tyr Asp Leu Gln Asn Arg Gln Ser Arg Leu
260 265 270
Pro Gly Thr Leu Val Ser Ser Thr Thr Lys Thr Phe Thr Ser Ser Ser
275 280 285
Gln Arg Ala Ala Val Asp Ala His Tyr Asn Leu Gly Lys Val Tyr Asp
290 295 300
Tyr Phe Tyr Ser Asn Phe Lys Arg Asn Ser Tyr Asp Asn Lys Gly Ser
305 310 315 320
Lys Ile Val Ser Ser Val His Tyr Gly Thr Gln Tyr Asn Asn Ala Ala
325 330 335
Trp Thr Gly Asp Gln Met Ile Tyr Gly Asp Gly Asp Gly Ser Phe Phe
340 345 350
Ser Pro Leu Ser Gly Ser Leu Asp Val Thr Ala His Glu Met Thr His
355 360 365
Gly Val Thr Gln Glu Thr Ala Asn Leu Ile Tyr Glu Asn Gln Pro Gly
370 375 380
Ala Leu Asn Glu Ser Phe Ser Asp Val Phe Gly Tyr Phe Asn Asp Thr
385 390 395 400
Glu Asp Trp Asp Ile Gly Glu Asp Ile Thr Val Ser Gln Pro Ala Leu
405 410 415
Arg Ser Leu Ser Asn Pro Thr Lys Tyr Asn Gln Pro Asp Asn Tyr Ala
420 425 430
Asn Tyr Arg Asn Leu Pro Asn Thr Asp Glu Gly Asp Tyr Gly Gly Val
435 440 445
His Thr Asn Ser Gly Ile Pro Asn Lys Ala Ala Tyr Asn Thr Ile Thr
450 455 460
Lys Leu Gly Val Ser Lys Ser Gln Gln Ile Tyr Tyr Arg Ala Leu Thr
465 470 475 480
Thr Tyr Leu Thr Pro Ser Ser Thr Phe Lys Asp Ala Lys Ala Ala Leu
485 490 495
Ile Gln Ser Ala Arg Asp Leu Tyr Gly Ser Thr Asp Ala Ala Lys Val
500 505 510
Glu Ala Ala Trp Asn Ala Val Gly Leu
515 520
<210> 14
<211> 381
<212> PRT
<213> ATCC6051
<400> 14
Met Arg Ser Lys Lys Leu Trp Ile Ser Leu Leu Phe Ala Leu Thr Leu
1 5 10 15
Ile Phe Thr Met Ala Phe Ser Asn Met Ser Ala Gln Ala Ala Gly Lys
20 25 30
Ser Ser Thr Glu Lys Lys Tyr Ile Val Gly Phe Lys Gln Thr Met Ser
35 40 45
Ala Met Ser Ser Ala Lys Lys Lys Asp Val Ile Ser Glu Lys Gly Gly
50 55 60
Lys Val Gln Lys Gln Phe Lys Tyr Val Asn Ala Ala Ala Ala Thr Leu
65 70 75 80
Asp Glu Lys Ala Val Lys Glu Leu Lys Lys Asp Pro Ser Val Ala Tyr
85 90 95
Val Glu Glu Asp His Ile Ala His Glu Tyr Ala Gln Ser Val Pro Tyr
100 105 110
Gly Ile Ser Gln Ile Lys Ala Pro Ala Leu His Ser Gln Gly Tyr Thr
115 120 125
Gly Ser Asn Val Lys Val Ala Val Ile Asp Ser Gly Ile Asp Ser Ser
130 135 140
His Pro Asp Leu Asn Val Arg Gly Gly Ala Ser Phe Val Pro Ser Glu
145 150 155 160
Thr Asn Pro Tyr Gln Asp Gly Ser Ser His Gly Thr His Val Ala Gly
165 170 175
Thr Ile Ala Ala Leu Asn Asn Ser Ile Gly Val Leu Gly Val Ala Pro
180 185 190
Ser Ala Ser Leu Tyr Ala Val Lys Val Leu Asp Ser Thr Gly Ser Gly
195 200 205
Gln Tyr Ser Trp Ile Ile Asn Gly Ile Glu Trp Ala Ile Ser Asn Asn
210 215 220
Met Asp Val Ile Asn Met Ser Leu Gly Gly Pro Thr Gly Ser Thr Ala
225 230 235 240
Leu Lys Thr Val Val Asp Lys Ala Val Ser Ser Gly Ile Val Val Ala
245 250 255
Ala Ala Ala Gly Asn Glu Gly Ser Ser Gly Ser Thr Ser Thr Val Gly
260 265 270
Tyr Pro Ala Lys Tyr Pro Ser Thr Ile Ala Val Gly Ala Val Asn Ser
275 280 285
Ser Asn Gln Arg Ala Ser Phe Ser Ser Ala Gly Ser Glu Leu Asp Val
290 295 300
Met Ala Pro Gly Val Ser Ile Gln Ser Thr Leu Pro Gly Gly Thr Tyr
305 310 315 320
Gly Ala Tyr Asn Gly Thr Ser Met Ala Thr Pro His Val Ala Gly Ala
325 330 335
Ala Ala Leu Ile Leu Ser Lys His Pro Thr Trp Thr Asn Ala Gln Val
340 345 350
Arg Asp Arg Leu Glu Ser Thr Ala Thr Tyr Leu Gly Asn Ser Phe Tyr
355 360 365
Tyr Gly Lys Gly Leu Ile Asn Val Gln Ala Ala Ala Gln
370 375 380
<210> 15
<211> 659
<212> PRT
<213> ATCC6051
<400> 15
Met Phe Ala Lys Arg Phe Lys Thr Ser Leu Leu Pro Leu Phe Ala Gly
1 5 10 15
Phe Leu Leu Leu Phe His Leu Val Leu Ala Gly Pro Ala Ala Ala Ser
20 25 30
Ala Glu Thr Ala Asn Lys Ser Asn Glu Leu Thr Ala Pro Ser Ile Lys
35 40 45
Ser Gly Thr Ile Leu His Ala Trp Asn Trp Ser Phe Asn Thr Leu Lys
50 55 60
His Asn Met Lys Asp Ile His Asp Ala Gly Tyr Thr Ala Ile Gln Thr
65 70 75 80
Ser Pro Ile Asn Gln Val Lys Glu Gly Asn Gln Gly Asp Lys Ser Met
85 90 95
Ser Asn Trp Tyr Trp Leu Tyr Gln Pro Thr Ser Tyr Gln Ile Gly Asn
100 105 110
Arg Tyr Leu Gly Thr Glu Gln Glu Phe Lys Glu Met Cys Ala Ala Ala
115 120 125
Glu Glu Tyr Gly Ile Lys Val Ile Val Asp Ala Val Ile Asn His Thr
130 135 140
Thr Ser Asp Tyr Ala Ala Ile Ser Asn Glu Val Lys Ser Ile Pro Asn
145 150 155 160
Trp Thr His Gly Asn Thr Gln Ile Lys Asn Trp Ser Asp Arg Trp Asp
165 170 175
Val Thr Gln Asn Ser Leu Leu Gly Leu Tyr Asp Trp Asn Thr Gln Asn
180 185 190
Thr Gln Val Gln Ser Tyr Leu Lys Arg Phe Leu Asp Arg Ala Leu Asn
195 200 205
Asp Gly Ala Asp Gly Phe Arg Phe Asp Ala Ala Lys His Ile Glu Leu
210 215 220
Pro Asp Asp Gly Ser Tyr Gly Ser Gln Phe Trp Pro Asn Ile Thr Asn
225 230 235 240
Thr Ser Ala Glu Phe Gln Tyr Gly Glu Ile Leu Gln Asp Ser Ala Ser
245 250 255
Arg Asp Ala Ala Tyr Ala Asn Tyr Met Asp Val Thr Ala Ser Asn Tyr
260 265 270
Gly His Ser Ile Arg Ser Ala Leu Lys Asn Arg Asn Leu Gly Val Ser
275 280 285
Asn Ile Ser His Tyr Ala Ser Asp Val Ser Ala Asp Lys Leu Val Thr
290 295 300
Trp Val Glu Ser His Asp Thr Tyr Ala Asn Asp Asp Glu Glu Ser Thr
305 310 315 320
Trp Met Ser Asp Asp Asp Ile Arg Leu Gly Trp Ala Val Ile Ala Ser
325 330 335
Arg Ser Gly Ser Thr Pro Leu Phe Phe Ser Arg Pro Glu Gly Gly Gly
340 345 350
Asn Gly Val Arg Phe Pro Gly Lys Ser Gln Ile Gly Asp Arg Gly Ser
355 360 365
Ala Leu Phe Glu Asp Gln Ala Ile Thr Ala Val Asn Arg Phe His Asn
370 375 380
Val Met Ala Gly Gln Pro Glu Glu Leu Ser Asn Pro Asn Gly Asn Asn
385 390 395 400
Gln Ile Phe Met Asn Gln Arg Gly Ser His Gly Val Val Leu Ala Asn
405 410 415
Ala Gly Ser Ser Ser Val Ser Ile Asn Thr Ala Thr Lys Leu Pro Asp
420 425 430
Gly Arg Tyr Asp Asn Lys Ala Gly Ala Gly Ser Phe Gln Val Asn Asp
435 440 445
Gly Lys Leu Thr Gly Thr Ile Asn Ala Arg Ser Val Ala Val Leu Tyr
450 455 460
Pro Asp Asp Ile Ala Lys Ala Pro His Val Phe Leu Glu Asn Tyr Lys
465 470 475 480
Thr Gly Val Thr His Ser Phe Asn Asp Gln Leu Thr Ile Thr Leu Arg
485 490 495
Ala Asp Ala Asn Thr Thr Lys Ala Val Tyr Gln Ile Asn Asn Gly Pro
500 505 510
Glu Thr Ala Phe Lys Asp Gly Asp Gln Phe Thr Ile Gly Lys Gly Asp
515 520 525
Pro Phe Gly Lys Thr Tyr Thr Ile Met Leu Lys Gly Thr Asn Ser Asp
530 535 540
Gly Val Thr Arg Thr Glu Lys Tyr Ser Phe Val Lys Arg Asp Pro Ala
545 550 555 560
Ser Ala Lys Thr Ile Gly Tyr Gln Asn Pro Asn His Trp Ser Gln Val
565 570 575
Asn Ala Tyr Ile Tyr Lys His Asp Gly Ser Arg Val Ile Glu Leu Thr
580 585 590
Gly Ser Trp Pro Gly Lys Pro Met Thr Lys Asn Ala Asp Gly Ile Tyr
595 600 605
Thr Leu Thr Leu Pro Ala Asp Thr Asp Thr Thr Asn Ala Lys Val Ile
610 615 620
Phe Asn Asn Gly Ser Ala Gln Val Pro Gly Gln Asn Gln Pro Gly Phe
625 630 635 640
Asp Tyr Val Leu Asn Gly Leu Tyr Asn Asp Ser Gly Leu Ser Gly Ser
645 650 655
Leu Pro His
<210> 16
<211> 267
<212> PRT
<213> ATCC6051
<400> 16
Met Glu Lys Ile Lys Val Cys Val Ala Asp Asp Asn Arg Glu Leu Val
1 5 10 15
Ser Leu Leu Ser Glu Tyr Ile Glu Gly Gln Glu Asp Met Glu Val Ile
20 25 30
Gly Val Ala Tyr Asn Gly Gln Glu Cys Leu Ser Leu Phe Lys Glu Lys
35 40 45
Asp Pro Asp Val Leu Val Leu Asp Ile Ile Met Pro His Leu Asp Gly
50 55 60
Leu Ala Val Leu Glu Arg Leu Arg Glu Ser Asp Leu Lys Lys Gln Pro
65 70 75 80
Asn Val Ile Met Leu Thr Ala Phe Gly Gln Glu Asp Val Thr Lys Lys
85 90 95
Ala Val Asp Leu Gly Ala Ser Tyr Phe Ile Leu Lys Pro Phe Asp Met
100 105 110
Glu Asn Leu Val Gly His Ile Arg Gln Val Ser Gly Asn Ala Ser Ser
115 120 125
Val Thr His Arg Ala Pro Ser Ser Gln Ser Ser Ile Ile Arg Ser Ser
130 135 140
Gln Pro Glu Pro Lys Lys Lys Asn Leu Asp Ala Ser Ile Thr Ser Ile
145 150 155 160
Ile His Glu Ile Gly Val Pro Ala His Ile Lys Gly Tyr Leu Tyr Leu
165 170 175
Arg Glu Ala Ile Ser Met Val Tyr Asn Asp Ile Glu Leu Leu Gly Ser
180 185 190
Ile Thr Lys Val Leu Tyr Pro Asp Ile Ala Lys Lys Phe Asn Thr Thr
195 200 205
Ala Ser Arg Val Glu Arg Ala Ile Arg His Ala Ile Glu Val Ala Trp
210 215 220
Ser Arg Gly Asn Ile Asp Ser Ile Ser Ser Leu Phe Gly Tyr Thr Val
225 230 235 240
Ser Met Thr Lys Ala Lys Pro Thr Asn Ser Glu Phe Ile Ala Met Val
245 250 255
Ala Asp Lys Leu Arg Leu Glu His Lys Ala Ser
260 265

Claims (10)

1.重组枯草芽孢杆菌在以酶法合成肌肽的废水为原料生产四氢嘧啶中的应用,所述重组枯草芽孢杆菌能够表达来源于嗜碱芽胞杆菌Bacillus alcalophilus DTY1的EctA、EctB和EctC。
2.根据权利要求1所述应用,其特征在于,所述EctA、EctB和EctC的编码基因为四氢嘧啶合成基因簇EctABC的编码基因,由启动子+EctA编码基因+间隔序列+EctB编码基因+间隔序列+EctC编码序列+终止子组成。
3.根据权利要求2所述应用,其特征在于,所述启动子为P43启动子、pHY300PLK载体上的启动子或来源于嗜碱芽胞杆菌Bacillus alcalophilus DTY1的天然启动子。
4.根据权利要求1所述应用,其特征在于,所述重组枯草芽孢杆菌无法表达四氢嘧啶跨膜转运蛋白OpuC。
5.根据权利要求1或4所述应用,其特征在于,所述重组枯草芽孢杆菌无法表达中性蛋白酶nprE、碱性蛋白酶aprE、淀粉酶amyE和芽孢形成转录因子spo0A。
6.根据权利要求4或5所述应用,其特征在于,所述无法表达通过敲除蛋白编码基因或通过GRISPR的方法在蛋白编码基因中引入终止密码子破坏其表达。
7.一种利用酶法合成肌肽的废水生产四氢嘧啶的方法,其特征在于,包括:
步骤1、提供酶法合成肌肽的废水;
步骤2、将权利要求1中的重组枯草芽孢杆菌接入所述废水中发酵,得到胞内含四氢嘧啶的发酵液,离心或板框压滤发酵液获取湿菌体;
步骤3、所述湿菌体破壁后经膜过滤,滤液利用阳离子交换树脂吸附四氢嘧啶,利用氨水洗脱四氢嘧啶;或
所述湿菌体用水搅拌洗涤,离心后上清液利用阳离子交换树脂吸附四氢嘧啶,利用氨水洗脱四氢嘧啶;或
所述湿菌体用乙醇浸提,浸提液回收乙醇后利用阳离子交换树脂吸附四氢嘧啶,利用氨水洗脱四氢嘧啶;
步骤4、洗脱后的四氢嘧啶经过精制得到四氢嘧啶成品。
8.根据权利要求7所述方法,其特征在于,所述酶法合成肌肽的废水为利用微生物发酵生产L-氨基酸连接酶的酶液,催化肌肽合成原料合成肌肽工艺中产生的废水,包括L-氨基酸连接酶发酵废水和L-氨基酸连接酶反应纯化废水。
9.根据权利要求8所述方法,其特征在于,所述L-氨基酸连接酶发酵废水经由以下方法获得:
能够表达L-氨基酸连接酶的转基因微生物菌株发酵后的发酵液离心分离得菌体液和上清液;菌体液匀质破菌、膜过滤得菌体碎片;上清液和菌体碎片液合并作为酶的发酵废水。
10.根据权利要求8所述方法,其特征在于,所述L-氨基酸连接酶反应纯化废水经由以下方法获得:
肌肽合成原料加入L-氨基酸连接酶的酶液进行反应,反应完成后得到肌肽粗品溶液,依次经过膜分离、离子交换柱层析、结晶工艺进行纯化获得肌肽纯品,被膜分离和离子交换柱层析截留的废液作为酶反应纯化废水。
CN202111021701.XA 2021-09-01 2021-09-01 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法 Pending CN113717998A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111021701.XA CN113717998A (zh) 2021-09-01 2021-09-01 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111021701.XA CN113717998A (zh) 2021-09-01 2021-09-01 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法

Publications (1)

Publication Number Publication Date
CN113717998A true CN113717998A (zh) 2021-11-30

Family

ID=78680669

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111021701.XA Pending CN113717998A (zh) 2021-09-01 2021-09-01 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法

Country Status (1)

Country Link
CN (1) CN113717998A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114180693A (zh) * 2021-12-02 2022-03-15 湖北远大生物技术有限公司 一种生物酶法生产氨基酸产生废水的综合处理方法及在制备鸟粪石中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101597581A (zh) * 2009-07-13 2009-12-09 华北电力大学 一种嗜碱芽孢杆菌及其培养方法和应用
CN102517306A (zh) * 2011-12-16 2012-06-27 山东潍坊润丰化工有限公司 四氢嘧啶合成酶基因、重组载体、重组工程菌及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101597581A (zh) * 2009-07-13 2009-12-09 华北电力大学 一种嗜碱芽孢杆菌及其培养方法和应用
CN102517306A (zh) * 2011-12-16 2012-06-27 山东潍坊润丰化工有限公司 四氢嘧啶合成酶基因、重组载体、重组工程菌及其应用

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
KUHLMANN AU.等: "Osmotically Regulated Synthesis of the Compatible Solute Ectoine in Bacillus pasteurii and Related Bacillus spp." *
姜蔚宇;陈荣忠;: "四氢嘧啶类物质的生物合成与转运途径及其生物学功能" *
张芳;沈国平;李永臻;朱德锐;: "相容溶质四氢嘧啶与羟基四氢嘧啶的代谢调控研究进展" *
张薇;胡跃高;张力群;高洪文;: "中度嗜盐菌DTY1的鉴定及其耐盐机制的初步分析" *
张薇;魏海雷;高洪文;黄国和;: "中度嗜盐菌四氢嘧啶合成基因的克隆与功能分析" *
林璐 等: "枯草芽孢杆菌底盘细胞的设计、构建与应用" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114180693A (zh) * 2021-12-02 2022-03-15 湖北远大生物技术有限公司 一种生物酶法生产氨基酸产生废水的综合处理方法及在制备鸟粪石中的应用

Similar Documents

Publication Publication Date Title
CN105039381B (zh) 一种麦芽糖诱导型海藻糖合酶合成工程菌及其制备方法与应用
CN110607313B (zh) 一种高产l-赖氨酸的重组菌株及其构建方法与应用
CN110106206B (zh) 一种提高l-赖氨酸产量及稳定性的谷氨酸棒状杆菌构建方法
CN110747206A (zh) 3-羟基-3-甲基戊二酸单酰辅酶a还原酶基因rkhmgr及其应用
CN115011616A (zh) 一种乙醛脱氢酶基因rkaldh及其应用
CN113667682B (zh) Yh66-rs11190基因突变体及其在制备l-缬氨酸中的应用
CN113717998A (zh) 重组枯草芽孢杆菌的应用和利用酶法合成肌肽的废水生产四氢嘧啶的方法
CN111534552B (zh) 谷氨酸的发酵生产及后处理
CN104212757A (zh) 利用大肠杆菌产γ-谷氨酰甲胺合成酶高效生产L-茶氨酸的方法
CN109371070A (zh) 一种高产α-酮异戊酸的方法
CN112646767B (zh) 具有增强的l-谷氨酸生产力的菌株及其构建方法与应用
WO2019207443A1 (en) An enzymatic process for the preparation of (r)-sitagliptin
CN111454918B (zh) 一种烯醇还原酶突变体及其在制备(r)-香茅醛中的应用
CN110846333B (zh) 一种deoB基因改造的重组菌株及其构建方法与应用
CN114349831B (zh) aspA基因突变体、重组菌及制备L-缬氨酸的方法
CN113621549A (zh) 重组枯草芽孢杆菌的应用和利用酶法合成烟酰胺单核苷酸的废水生产四氢嘧啶的方法
CN113604415A (zh) 重组枯草芽孢杆菌的应用和利用酶法合成n-乙酰神经氨酸的废水生产四氢嘧啶的方法
CN113637624A (zh) 一种重组枯草芽孢杆菌及其应用和利用酶法合成谷胱甘肽的废水生产四氢嘧啶的方法
CN110862940B (zh) 一种谷氨酸棒杆菌工程菌及其在制备l-色氨酸中的应用
CN114181288A (zh) 制备l-缬氨酸的方法及其所用的基因与该基因编码的蛋白质
CN114672525A (zh) N-乙酰基-5-甲氧基色胺的生物合成方法及其应用
CN108753810B (zh) 一种转录调节蛋白基因orf2的用途
CN114277069B (zh) 制备l-缬氨酸的方法及其所用生物材料
CN107810269A (zh) 新颖的启动子及其用途
CN111139207A (zh) 一种短短芽孢杆菌基因重组菌株及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination